Skip to main content
. 2022 Sep 21;12:988458. doi: 10.3389/fonc.2022.988458

Figure 5.

Figure 5

Long-term clinical outcomes among patients with progressive nasopharyngeal carcinoma. (A) Kaplan–Meier analysis of overall survival (OS) among patients with epithelial/mesenchymal (E/M) hybrid-predominant or non-E/M hybrid-predominant distribution of circulating tumor cells (CTCs). (B) Kaplan–Meier analysis of disease-free survival (DFS). (C) Kaplan–Meier analysis of local relapse-free survival (LRFS). (D) Kaplan–Meier analysis of distant metastasis-free survival (DMFS). The log-rank test was performed for between-group comparisons of survival curves.